+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Aclaris Therapeutics

ACRSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Aclaris Therapeutics (ACRS) Forecast

News

Earnings Aclaris Therapeutics (ACRS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Aclaris Therapeutics (NASDAQ:ACRS) Stock

Aclaris Therapeutics Stock (NASDAQ: ACRS)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, November 19, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
Vandana Singh
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Leerink Partners Upgrades Aclaris Therapeutic...
Benzinga Newsdesk
Jefferies Upgrades Aclaris Therapeutics to Bu...
Benzinga Newsdesk
Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
BTIG Upgrades Aclaris Therapeutics to Buy, An...
Benzinga Newsdesk

Monday, November 18, 2024

Piper Sandler Upgrades Aclaris Therapeutics t...
Benzinga Newsdesk
Aclaris Therapeutics Shares Spike Higher; Pip...
Benzinga Newsdesk
Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
Aclaris Therapeutics Secures $80M Through Pri...
Benzinga Newsdesk
Aclaris Therapeutics Announces Exclusive, Glo...
Benzinga Newsdesk

Wednesday, November 06, 2024

Aclaris Had Aggregate Cash, Cash Equivalents ...
Benzinga Newsdesk
Aclaris Therapeutics Q3 2024 GAAP EPS $(0.11)...
Benzinga Newsdesk

Monday, October 28, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Friday, October 25, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, September 17, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk
Aclaris Therapeutics Doses First Patient In P...
Benzinga Newsdesk

Monday, August 19, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk

Wednesday, August 07, 2024

Aclaris' Cash, Cash Equivalents And Marketabl...
Benzinga Newsdesk
Aclaris Therapeutics Q2 2024 GAAP EPS $(0.15)...
Benzinga Newsdesk

Tuesday, July 23, 2024

Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor

Monday, July 22, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk

Tuesday, July 16, 2024

Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
Aclaris Therapeutics Sells OLUMIANT Royalties...
Benzinga Newsdesk

Tuesday, July 09, 2024

Is ADMA Biologics Stock Outpacing Its Medical Peers This Year?
Zacks

Monday, July 08, 2024

Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
Avi Kapoor

Friday, June 14, 2024

$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor

Friday, May 24, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, May 07, 2024

Aclaris Therapeutics Q1 EPS $(0.24) Beats $(0...
Benzinga Newsdesk

Monday, May 06, 2024

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
Zacks

Wednesday, March 06, 2024

Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor

Tuesday, February 27, 2024

Aclaris Therapeutics: Q4 Earnings Insights
Benzinga Insights

Monday, January 22, 2024

Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
Vandana Singh
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
HC Wainwright & Co. Downgrades Aclaris Therap...
Benzinga Newsdesk

Tuesday, January 16, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
Vandana Singh
Aclaris Therapeutics Announced That Douglas M...
Benzinga Newsdesk

Thursday, January 11, 2024

The Analyst Landscape: 4 Takes On Aclaris Therapeutics
Benzinga Insights
BTIG Downgrades Aclaris Therapeutics to Neutr...
Benzinga Newsdesk

Wednesday, January 10, 2024

Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Vandana Singh
Crude Oil Falls 1%; Amarin Shares Spike Higher
Avi Kapoor
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
Avi Kapoor
Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial
Vandana Singh
Dow Surges 100 Points; PriceSmart Earnings Top Views
Avi Kapoor

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved